Pfizer Inc. (NYSE: PFE) has announced that it will soon trade ex-dividend. This announcement signals the company’s investors to make their moves. The ex-dividend date refers to the day before a company decides which of its shareholders will get a dividend. Pfizer’s dividend will be $0.40 per share. Pfizer announces the real-world benefits of IBRANCE […]
FDA
Pfizer Inc. (NYSE: PFE) Finds That Paxlovid Cannot Prevent COVID-19 Infection
Pfizer Inc. (NYSE: PFE) has found that its Paxlovid pill might not effectively prevent COVID-19 in people who have come in contact with infected individuals. Paxlovid is an oral drug which the Food and Drug Administration (FDA) approved for the treatment of COVID-19. In the study, the company gave the pill to people for five […]
Pfizer Inc. (NYSE: PFE) Drug, Paxlovid, Becomes Readily Available As Omicron Subsides
The Pfizer Inc. (NYSE: PFE) drug, Paxlovid, is becoming more available as the number of omicron infections dwindles. The drug which the Food and Drug Administration (FDA) approved had been difficult to obtain during the spike, leaving a gap for patients with mild cases of the disease. Meanwhile, Pfizer and BioNTech SE’s (NASDAQ: BNTX) omicron […]
Regular Allows Moderna Inc (NASDAQ:MRNA) To Fill About 15 Doses Per Vaccine Vial
Moderna will start speeding up its COVID-19 vaccine output after getting a nod from the U.S. Food and Drug Administration (FDA). The company swings into action, filling each vial with about 15 doses. The United States is concerned about spreading the deadly virus and channeling resources to support rapid immunization activities. The nod The drug […]
Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By Spring
Johnson & Johnson (NYSE:JNJ) is expecting that by April it will have adequate COVID-19 vaccine doses for over 100 million Americans as nationwide vaccination efforts ramp up. JNJ to ramp up vaccine production Dr. Mark McClellan, the company’s board member, and former FDA administrator indicated that JNJ will go all out in the production of […]
Pfizer Inc. (NYSE:PFE) To Use Own Distribution Channel For COVID-19 Vaccines Instead Of Government Channel
Pfizer Inc. (NYSE:PFE) is planning to go alone to distribute the COVID-19 vaccine in the US once the FDA approves it instead of distributing it through the designated government coordinator. Officials have questioned whether there is an adequate supply of medical-grade freezers in the US at the point of use for vaccines that need storages […]
Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments
Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first drugmaker to include children in their COVID-19 vaccine trials, and this has drawn divided reactions from different people. Pfizer testing vaccine in 3,000 teens The New York Pharms received approval […]
Novan Inc. (NASDAQ:NOVN) Has Around $17 Million To Fund Phase 3 SB206 Trial In Molluscum
Novan Inc. (NASDAQ: NOVN) announced that it expects its current cash to be adequate for funding the additional third phase pivotal SB206 study in treating patients with molluscum or B-SIMPLE4. Novan has almost 17 million for conducting phase 3 SB206 trial Since the beginning of June, Novan has secured around $16.9 million from common shares […]
Gilead Sciences, Inc. (NASDAQ:GILD) Reports Minor Benefits Of Remdesivir In COVID-19 Patients
Gilead Sciences, Inc. (NASDAQ:GILD) released an update about its developmental COVID-19 vaccine remdesivir, revealing that the treatment yielded modest improvements in patients. Coronavirus patients who were administered with remdesivir intravenously for five days demonstrated moderate improvements. However, the COVID-19 patients that were treated with the drug for 10-days did not yield significant improvements. Remdesivir was […]
Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”
The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]
Capital Flowing Back into Cannabis Stocks (GWPH, CGC, MCTC, TCNNF)
Cannabis investors have been burnt by oversupply and a proliferation of pretenders over the past two years. But the sun is finally starting to come back out from behind those clouds over the past month, with many survivors starting to show signs of thriving in the post-purge world that now defines the space. The pandemic […]
InVivo Therapeutics Staggers over Recent Positive News (NVIV)
Two weeks ago, InVivo Therapeutics (OTC: NVIV) released second quarter financial results that showed a pro forma loss of $0.04 versus a loss $0.05 for the same period last year. The company also mentioned the clinical progress for its biopolymer scaffolding and hydrogel technologies. According to the report, the FDA is prepared to clear the […]
A Pristine Day for Pristine Solutions while Nokia Slides (PRTN)
Despite flooding the market with Windows-powered smartphones, troubles for Nokia (NYSE: NOK) are far from over. On the other hand, Pristine Solutions (OTC: PRTN) is having a field day in the OTC market buoyed by its recent acquisition of Eaton Scientific Systems. Market forces are applying increasing pressure to behemoths like Apple, Microsoft and Google […]
Cytomedix Share Price Surges After Coverage Determination Granted by CMS (CMXI)
Cytomedix (OTC: CMXI) staged a huge rally in today’s trading session after informing the public that the Center for Medicare & Medicaid Services (CMS) granted Coverage with Evidence Development (CED) for the Cytomedix AutoloGel products. Today’s press release mentions that the Centers for Medicare & Medicaid Services issued a National Coverage Determination (NCD) on August 2, […]
Medicare Approval Has Seniors Jumping for Joy, Breaking Hips (TBIO)
For nearly 50 million Americans, Medicare approval is crucial for determining what medical procedures one can undergo. Transgenomic (OTC: TBIO) stated today that after quite a bit of legal wrangling and waiting, it had finally received Medicare’s endorsement for its Clopidogrel Genetic Absorption Activation Panel. This simple saliva test is used to identify patients who […]
